1. Home
  2. ONCY vs KBSX Comparison

ONCY vs KBSX Comparison

Compare ONCY & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • KBSX
  • Stock Information
  • Founded
  • ONCY 1998
  • KBSX 1976
  • Country
  • ONCY Canada
  • KBSX Taiwan
  • Employees
  • ONCY N/A
  • KBSX N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • KBSX Recreational Games/Products/Toys
  • Sector
  • ONCY Health Care
  • KBSX Consumer Discretionary
  • Exchange
  • ONCY Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • ONCY 89.7M
  • KBSX 74.8M
  • IPO Year
  • ONCY 1999
  • KBSX N/A
  • Fundamental
  • Price
  • ONCY $1.06
  • KBSX $1.68
  • Analyst Decision
  • ONCY Strong Buy
  • KBSX
  • Analyst Count
  • ONCY 5
  • KBSX 0
  • Target Price
  • ONCY $5.00
  • KBSX N/A
  • AVG Volume (30 Days)
  • ONCY 681.0K
  • KBSX 17.8K
  • Earning Date
  • ONCY 08-08-2025
  • KBSX 08-21-2025
  • Dividend Yield
  • ONCY N/A
  • KBSX N/A
  • EPS Growth
  • ONCY N/A
  • KBSX N/A
  • EPS
  • ONCY N/A
  • KBSX N/A
  • Revenue
  • ONCY N/A
  • KBSX $40,863,331.00
  • Revenue This Year
  • ONCY N/A
  • KBSX N/A
  • Revenue Next Year
  • ONCY N/A
  • KBSX N/A
  • P/E Ratio
  • ONCY N/A
  • KBSX N/A
  • Revenue Growth
  • ONCY N/A
  • KBSX 20.42
  • 52 Week Low
  • ONCY $0.33
  • KBSX $1.26
  • 52 Week High
  • ONCY $1.53
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 54.04
  • KBSX N/A
  • Support Level
  • ONCY $0.95
  • KBSX N/A
  • Resistance Level
  • ONCY $1.07
  • KBSX N/A
  • Average True Range (ATR)
  • ONCY 0.08
  • KBSX 0.00
  • MACD
  • ONCY 0.01
  • KBSX 0.00
  • Stochastic Oscillator
  • ONCY 81.89
  • KBSX 0.00

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: